Real-World Effectiveness and Treatment Persistence of Darolutamide, Apalutamide, and Enzalutamide in Non-Metastatic Castration-Resistant Prostate Cancer: A Multicenter Study.

Saved in:
Bibliographic Details
Title: Real-World Effectiveness and Treatment Persistence of Darolutamide, Apalutamide, and Enzalutamide in Non-Metastatic Castration-Resistant Prostate Cancer: A Multicenter Study.
Authors: Hara S; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan; Department of Urology, Jikei Katsushika Medical Center, Tokyo, Japan. Electronic address: sharahara2@gmail.com., Mori K; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Hashimoto M; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan; Department of Urology, Jikei Katsushika Medical Center, Tokyo, Japan., Yata Y; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Kurawaki S; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan; Department of Urology, Machida Municipal Hospital, Tokyo, Japan., Iwamoto Y; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan; Department of Urology, Atsugi City Hospital, Kanagawa, Japan., Kawano S; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan; Department of Urology, Tokyo-Kita Medical Center, Tokyo, Japan., Otsuka T; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan; Department of Urology, Nerima Hikarigaoka Hospital, Tokyo, Japan., Fukuokaya W; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Miyajima K; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Department of Urology, Ota Memorial Hospital, Gunma, Japan., Ishikawa M; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan; Department of Urology, Tokyo Metropolitan Hiroo Hospital, Tokyo, Japan., Kurokawa G; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan; Department of Urology, JR Tokyo General Hospital, Tokyo, Japan; Department of Urology, Saitama Northern Medical Center, Saitama, Japan., Imai Y; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan; Department of Urology, Fuji City General Hospital, Shizuoka, Japan., Nakazono M; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan; Department of Urology, Kameda General Hospital, Chiba, Japan., Atsuta M; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan; Department of Urology, Jikei Kashiwa Hospital, Chiba, Japan., Urabe F; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan; Department of Urology, Jikei the 3rd Hospital, Tokyo, Japan., Yanagisawa T; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Tsuzuki S; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Shimomura T; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan; Department of Urology, Jikei the 3rd Hospital, Tokyo, Japan., Yamada H; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan; Department of Urology, Jikei Katsushika Medical Center, Tokyo, Japan., Kimura T; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
Source: Clinical genitourinary cancer [Clin Genitourin Cancer] 2026 Jun; Vol. 24 (4), pp. 102546. Date of Electronic Publication: 2026 Mar 21.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101260955 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0682 (Electronic) Linking ISSN: 15587673 NLM ISO Abbreviation: Clin Genitourin Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1938-0682
DOI:10.1016/j.clgc.2026.102546